Clinical Trial Update: Systemic Chemotherapy Versus Transcatheter Arterial Chemoembolization(TACE) for Hepatocellular Carcinoma [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial comparing systemic chemotherapy to transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Guangxi Medical University | Conditions: Hepatocellular Carcinoma | Phase 2, Phase 3 | Status: WITHDRAWN